We have investigated the phenotypic changes that take place during the process of neoplastic transformation in the thymocytes of C57BL/Ka mice infected by the radiation leukemia virus (RadLV). By the combined use of antibodies against the envelope glycoprotein gp7O of RadLV, the transformation-associated cell surface marker lC1l, and the CD3-T-cell receptor (TCR) complex, we found that in the RadLV-infected thymus, the earliest expression of viral gp7O is in lCllhi cells; a small but significant percentage of these cells also express CD3. A first wave of viral replication, manifested by the expression of high levels of gp7O in thymocytes (over 70% positive), reaches a peak at 2 weeks; during this period, no significant changes are observed in the expression of IC11 or CD3. The population of gp70+ cells is drastically reduced at 3 to 4 weeks after infection. However, a second cohort of gp70+ cells appears after 4 weeks, and these cells express high levels of lCll and TCR determinants as well. RadLV-induced lymphomas differ from normal thymocytes in their CD4 CD8 phenotype, with domination by one or more subsets. Characterization of TCR gene rearrangements in RadLV-induced lymphomas shows that most of these tumors are clonal or oligoclonal with respect to the JP2 TCR gene, while the Jjll TCR gene is rearranged in a minority (4 of 11) of lymphomas. TCR VP repertoire analysis of 12 tumors reveals that 6 (50%o) express exclusively the V,I6 gene product, 2 (17%) are V05', and 1 (8%) each are VP8+ and VP9+. In normal C57BL/Ka mice, VPI6 is expressed on 12%, VII5 is expressed on 9%, V,B8 is expressed on 22%, and Vj89 is expressed on 4% of TCRhi thymocytes. Thus, it appears that RadLV-induced thymic lymphomas are not randomly selected with respect to expressed TCR VP type.
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Exposure to ionizing radiation is known to induce lymphoid malignancy in humans; the incidence of acute lymphoblastic leukemia in particular has been shown to correlate with radiation dose (34) . To facilitate investigation of the basic mechanisms by which radiation induces leukemia, Kaplan and colleagues developed a murine model (21, 22) which they used to define the parameters for T-cell transformation. Wholebody irradiation, administered in fractionated doses, was found to induce a high incidence (>90%) of thymus-dependent lymphomas in C57BL/Ka mice (22) . A thymotropic and lymphomagenic retrovirus, the radiation leukemia virus (RadLV), was recovered from cell extracts of some of these lymphomas (29, 30) . After serial in vivo passage, RadLV-induced thymic lymphomas were found to be similar in frequency, clinical aspects, and latency to those produced by radiation. Several lymphoma cell lines from RadLV-induced tumors were established in culture (27) ; one such cell line, BLNVL3, was used to molecularly clone the RadLV proviral genome, and its complete nucleotide sequence has been determined (33) . It is believed that RadLV and other thymotropic and leukemogenic murine leukemia viruses (MuLVs) have evolved as a result of recombinational events between ecotropic and xenotropic endogenous retroviral sequences present in the mouse genome (4) .
Structural analysis of the viral genome revealed the presence of tandem repeats in the long terminal repeat region, similar to those observed in other leukemogenic retroviruses (8, 24, 26) . The repeats are believed to be responsible, in part, for the tissue tropism and leukemogenicity of these viruses (8, 26) . Studies of recombinant nonleukemogenic and leukemogenic mink cell focus-forming viruses have shown that, in addition to the long terminal repeat, the envelope gene product also determines the leukemogenic potential of MuLVs (9, 17) . Although elucidation of the molecular and structural properties of RadLV has advanced our understanding of the virus, the mechanism by which RadLV causes T-cell transformation is still unclear. The receptor-mediated leukemogenesis hypothesis (47) proposes a possible step in the pathway for retrovirusinduced neoplastic transformation. It proposes that a crucial step is the binding of MuLV to a cell surface mitogen receptor such as the clonotypic T-cell receptor (TCR) on target T cells, presumably inducing mitogenic signal transduction. Subsequently, O'Neill et al. demonstrated that in the T-cell lymphoma line C6VL, binding of the retrovirus may be blocked by the TCR clonotypic antibody and that, as a result, proliferation of the leukemic cells is inhibited (38) . Other steps in the process have also been proposed, including activation of proto-oncogenes by nearby integration of retroviral genes with enhancer activity (16, 26) .
The target cell type and the events occurring in the course of lymphomagenesis within the infected thymus have yet to be fully defined. The availability of monoclonal antibodies against T-cell differentiation antigens (3, 25) and the transformationassociated antigen 1C1 1 (28, 41) Cell lines and antibodies. The T-cell lymphoma lines used in these studies were BL/RL12, a MuLV-free cell line derived from a radiation-induced C57BL/Ka thymoma, and BL/VL3, a MuLV-producing cell line derived from a RadLV-induced thymoma (27) . The anti-RadLV gp7O hybridoma clone JM11 was generated by fusing splenocytes from a rat immunized against the BL/VL3 cell line with the mouse myeloma cell line XAg63. All experiments described here were carried out with the hybridoma culture supernatant. Sources, specificities, and fluorochrome modifications of monoclonal antibodies specific for CD3, CD4, CD8, lCll, and ox3TCR have been described elsewhere (41, 42 (VP3 [39] ), MR9-4 (V,5 [40] ), (V16 [20] ), R-310 (V,B7 [37] ), F23.1 (V38.1-8.3 [43] ), (V,B8.1-8.2 [23] ), MR10-2 (V,B9 [46] ), RR3-15 (V3ll [5] ), and MR12-3 (VP13 [48] ). The antibodies against V,B -3, -5, -6, -9, -11, and -13 were generous gifts from 0. Kanagawa Flow cytometric analysis. The immunofluorescence staining procedure for one-, two-, three-, and four-color assays has been described in detail elsewhere (41, 42) . The fluorescence of stained normal or RadLV-infected thymocytes and of thymic lymphomas was analyzed on a highly modified duallaser FACS IV (Becton Dickinson) with four-decade logarithmic amplifiers as described previously (41) . Dead cells were gated out with 1 pLg of propidium iodide per ml except for four-color analysis, in which case the scatter-gating method was used and the excitation wave length of the dye laser was raised from 598 to 605 nm. Fluorescence profiles were analyzed by using FACS/DESK software programs to generate either histograms or two-parameter probability (5%) contour plots in which both x and y axes represent fluorescence intensity on a logarithmic scale. In describing the results, we use the terms "hi" and "lo" as relative indicators of staining intensity; hi cells usually stain at least 5-to 10- (anti-RadLV gp7O) was allowed to react with 50 ptl of rabbit anti-rat Ig coupled to protein A-Sepharose beads (Sigma Chemical Co., St. Louis, Mo.). The beads were then incubated with 251I-labeled cell lysates (500 RIb) and washed five times with 0.5% Nonidet P40-containing lysis buffer, and the antigen was finally eluted from the beads with 50 ,u of sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample buffer. The immunoprecipitated antigen was run on SDS-12% polyacrylamide gels under reducing conditions. After drying, the gels were subjected to autoradiography using Kodak X-Omat AR films (Eastman Kodak, Rochester, N.Y.) and Dupont Cronex Lighting Plus intensifying screens (DuPont Co., Wilmington, Del.).
Preparation of DNA and Southern blot hybridization. Highmolecular-weight DNA was isolated by proteinase K digestion followed by phenol-chloroform extraction. DNA was digested with the restriction enzyme EcoRI, and restriction fragments were electrophoretically separated on 0.8% agarose gels. The DNA was acid depurinated before denaturation and transferred onto a nylon membrane. The filters were hybridized with 2 x 106 cpm of random hexamer-labeled probes (10) per ml in a hybridization mixture containing 50% formamide, DNA (100 mg/ml) at 42°C (11) . The filters were washe 0.1 x SSC-0.1% SDS at 55°C and subjected to autorac phy as described above.
DNA probes. The probes used to detect TCR rear ments were specific for the J,1l and J,B2 gene segments TCR P locus (11) . The (Fig. 3A) . Most of these cells did not express lCll of the (Fig. 3B) or CD3 (Fig. 3C) second wave of gp7O expression was permanent and was accompanied by parallel increases in cells expressing IC1 1 and CD3 (Fig. 3) . Cells bearing these three markers predominated thereafter, including the majority of cells in overt lymphomas.
CD4 CD8 phenotypes of RadLV-infected thymocytes and of primary lymphomas. No significant difference from normal cells was detected in the overall CD4 CD8 profiles of thymocytes from infected mice (data not shown) during the first 4 weeks after RadLV infection. The CD4 CD8 profiles of the resulting lymphomas were variable, and a representative set of data is presented in Fig. 4 along with the profile of normal thymocytes for comparison (Fig. 4A) . Two of the lymphomas consisted predominantly of CD4+ CD8 -cells ( Fig. 4B and C) , while the third lymphoma was a mixture of CD4+ CD8+ and CD4-CD8+ cells (Fig. 4D) , a phenotype very frequently observed in primary radiation-induced lymphomas (40a). The composition of nine individual RadLV-induced lymphomas with respect to cells expressing IC11, gp7O, CD3, CD4, and CD8 is presented in Table 1 . Unlike radiation-induced lymphomas, which are usually a mixture of CD4-CD8+ and CD4+ CD8+ cells, the majority of RadLV-induced lymphomas were found to be heterogeneous with respect to CD4 CD8 phenotypes ( Table 1) . Four of eight lymphomas contained predominantly CD4+ CD8-cells (>60%), and two consisted largely of the CD4+ CD8+ cell type (>60%). Of the remaining two tumors, one contained >70% CD4+ CD8+ cells, while the other one was a mixture of CD4+ CD8+ and CD4-CD8+ cells. All lymphomas had also a small but significant percentage of CD4 -CD8 -cells. Various proportions of cells in the lymphomas, from <50 to >90%, expressed the gp7O, lCll, and CD3 markers (Table 1) .
Since the majority of lymphomas coexpressed CD3 and gp7O, 1 week after infection, we reanalyzed the profiles of the gp70+ and gp70-thymocyte populations in infected mice with respect to CD3 expression subsets. In both populations, the CD3 -"°subsets showed a normal pattern of CD4 and CD8 expression, that of immature and nonmature CD4+ CD8+ thymocytes (data not shown). However, the CD3hi subset was different: the infected population (gp70+) consisted predominantly of CD4+ CD8-and CD4+ CD8+ subsets and a few CD4-CD8+ cells, whereas the CD4 CD8 phenotype of the uninfected population (gp7O ) was that of normal thymocytes (data not shown). to EcoRI-digested DNA obtained from RadLV-induced lymphomas; the results are presented in Fig. 6 . All of the 11 tested lymphomas showed clonal or oligoclonal J12 gene rearrangements as well as variable amounts of the 2.5-kb germ line JP2 gene structure (Fig. 6A) . Four of the lymphomas (lymphomas 1, 2, 3, and 7) also displayed clonal J,1 gene rearrangements, while the remainder had the germ line J,B1 gene structure (not shown). Three lymphomas (lymphomas 7, 9, and 11), in which the expression of the TCR was exclusively VP6, were oligoclonal with respect to the JP2 TCR gene structure; one (lymphoma 7) also exhibited a clonal rearrangement of the J,1l gene (Fig. 6B) . In the VP6-expressing tumors, the sizes of the rearranged J,B2 gene differed, indicating that different recombinational events led independently to each of these tumors.
DISCUSSION
We have previously described a cell population in the thymuses of irradiated mice in which the first transformationassociated changes, and the phenotypic evolution during progression toward frank malignancy, can be detected (28, 41) . It was shown that these cells express a surface glycoprotein, iClC, also present on 10% of normal thymocytes (the immature subset) and on virtually all neoplastic T cells (28, 41) . On preneoplastic and neoplastic, but not on normal immature, thymocytes, the lCil molecule is coexpressed with the differentiation marker CD3 of the TCR complex. The earliest identifiable preneoplastic thymocytes in these irradiated mice (6) suggest that while many thymocytes are susceptible to productive infection by the virus, most do not undergo neoplastic transformation and die intrathymically. A relatively rare thymocyte subset, infected initially or secondarily, is presumably the target for transformation. It may be the population identified by early coexpression of gp7O and CD3, which begins to expand at 4 to 5 weeks after infection. As in irradiated mice, leukemic progression is marked by increasing numbers of ICII+ and CD3+ thymocytes. However, unlike the predominantly CD4-CD8+ and CD4+ CD8+ radiation-induced lymphomas (40a), RadLVinduced tumors are heterogeneous with respect to their CD4 CD8 phenotype, and a significant number are CD4+ CD8 -, a phenotype not observed in the former but reported in AKR virus-induced lymphomas (15) and the RadLV-binding C6VL lymphoma cell line (38) .
It has been postulated that a critical step by which retroviruses cause thymic lymphomas in mice is via their binding to the cognate TCR on thymocytes, with resultant persistent stimulation and eventual transformation of the cells (32, 38) . The (1, 45) and experimental myasthenia gravis (19) . In addition, tumor-infiltrating T cells in uveal melanoma in human (36) and Friend virus-induced tumors in mice (44) were shown to express specific TCR Vot and V,B genes. In a recent study, Hugin et al. demonstrated that a replication-defective MuLV that induces murine AIDS encodes a superantigen that stimulates V,B5-positive CD4+ CD8 -T cells (18) . Our observation of the clonal expansion of a subset of VP-bearing T-lymphoma cells in RadLV-induced lymphomagenesis suggests that a particular set of the VP repertoire such as V36 of the TCR may be important in the pathophysiology of the disease. In many of the autoimmune diseases mentioned above, the specificity of the antigens that cause stimulation of autoreactive T cells has been well characterized. Such precise determination of the antigenic components of RadLV that may bring about stimulation and clonal expansion of a particular V,B-bearing T cells has not been made. Nevertheless, in light of the theory of receptor-mediated leukemogenesis, such a mechanism may well be operative through interaction between the viral envelope antigen and the V,B subunit of the TCR. Determination of antigenic specificities of retrovirus-induced T-cell lymphomas may eventually help us to understand the biochemical basis of cellular proliferation and transformation. It would also be of interest to examine whether ablation of V,B6+ thymocytes by antibody administration would reduce the incidence or delay the appearance of virus-induced lymphomas. In this regard, it is important to note that treatment of mice with anti-V,B8 antibody could abrogate the ability to transfer experimental autoimmune encephalomyelitis in PL/J mice (49 
